CefeCure 1g
1 Vial + 10 ml Ampoule
• Cefepime 1g Injection
• Fourth-Generation Cephalosporin Antibiotic
• Supports Treatment of Bacterial Infections
• Sterile Powder for Reconstitution
• For Professional Healthcare Use
- Description
Description
CefeCure 1g
Each vial contains:
Cefepime Hydrochloride, USP eq. to Cefepime 1 g
Each ampoule contains: Sterile Water for injection, USP 10 mL
PRODUCT DESCRIPTION:
A white to pale yellow powder, after reconstitution with Sterile Water for Injection, it forms white to yellowish coloured clear solution.
Indications:
Cefepime is a fourth-generation cephalosporin antibacterial used in the treatment of infections due to susceptible organisms. They
include infections of the urinary tract, respiratory tract, and skin.
Ideally, antibacterial treatment of infections should be chosen after the infecting organisms have been identified and the results of
sensitivity tests are known. In practice, empirical treatment is often necessary initially, bearing in mind local patterns of infections and
resistance. Other factors such as site of infection and tissue penetration are also important in deciding which antibacterial to give. The
prophylactic use of antibacterial is restricted mainly to patients undergoing some types of surgery.
Other groups requiring infection prophylaxis include patients at special risk of developing endocarditis and those who have had
rheumatic fever, who are splenectomised, or who are immunocompromised.
include infections of the urinary tract, respiratory tract, and skin.
Ideally, antibacterial treatment of infections should be chosen after the infecting organisms have been identified and the results of
sensitivity tests are known. In practice, empirical treatment is often necessary initially, bearing in mind local patterns of infections and
resistance. Other factors such as site of infection and tissue penetration are also important in deciding which antibacterial to give. The
prophylactic use of antibacterial is restricted mainly to patients undergoing some types of surgery.
Other groups requiring infection prophylaxis include patients at special risk of developing endocarditis and those who have had
rheumatic fever, who are splenectomised, or who are immunocompromised.
